85 related articles for article (PubMed ID: 19919788)
1. Value of (99m)Tc tetrofosmin scan in well-differentiated thyroid cancer.
Gallegos-Hernández JF; Pichardo-Romero P; Esparza-Pérez H; Reséndiz-Colosia JA; Minauro-Muñoz GG; Hernández-Hernández DM
Cir Cir; 2009; 77(4):275-8; 257-9. PubMed ID: 19919788
[TBL] [Abstract][Full Text] [Related]
2. Role of 99mTc-Tetrofosmin delayed scintigraphy and color Doppler sonography in characterization of solitary thyroid nodules.
Sharma R; Chakravarty KL; Tripathi M; Kaushik A; Bharti P; Sahoo M; Chopra MK; Rawat H; Misra A; Mondal A; Kashyap R
Nucl Med Commun; 2007 Nov; 28(11):847-51. PubMed ID: 17901767
[TBL] [Abstract][Full Text] [Related]
3. The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter.
Karayalçin U; Ciftçi F; Boz A; Boz S; Karayalçin B
Ann Nucl Med; 1997 Nov; 11(4):285-90. PubMed ID: 9460519
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.
Kresnik E; Gallowitsch HJ; Mikosch P; Molnar M; Pipam W; Gomez I; Lind P
Eur J Nucl Med; 1997 Jul; 24(7):716-21. PubMed ID: 9211755
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
7. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
[TBL] [Abstract][Full Text] [Related]
8. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.
Giovanella L; Suriano S; Maffioli M; Ceriani L; Spriano G
Head Neck; 2010 May; 32(5):607-11. PubMed ID: 19693945
[TBL] [Abstract][Full Text] [Related]
9. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of 99mTc-pertechnetate scintigraphy and fine-needle aspiration cytology in patients with solitary thyroid nodules and thyroid cancer.
Lumachi F; Varotto L; Borsato S; Tregnaghi A; Zucchetta P; Marzola MC; Cecchin D; Bui F
Anticancer Res; 2004; 24(4):2531-4. PubMed ID: 15330209
[TBL] [Abstract][Full Text] [Related]
12. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
Adalet I; Demirkale P; Unal S; Oůz H; Alagöl F; Cantez S
Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
[TBL] [Abstract][Full Text] [Related]
13. Relation between (99m)Tc-tetrofosmin thyroid scintigraphy and mitogen-activated protein kinase in papillary thyroid cancer patients.
Baba K; Ishibashi M; Kaida H; Fujii T; Hiromatsu Y; Kawahara A; Kage M; Hayabuchi N
Jpn J Radiol; 2011 Oct; 29(8):533-9. PubMed ID: 21927994
[TBL] [Abstract][Full Text] [Related]
14. The role of 99Tcm-tetrofosmin in the evaluation of thyroid nodules.
Kanmaz B; Erdil TY; Yardi OF; Sayman HB; Kabasakal L; Sönmezoglu K; Onsel C; Düren M; Nisli C; Ozcan K; Uslu I
Nucl Med Commun; 2000 Apr; 21(4):333-9. PubMed ID: 10845221
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
Gallowitsch HJ; Kresnik E; Mikosch P; Pipam W; Gomez I; Lind P
Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer.
Klain M; Maurea S; Lastoria S; Cuocolo A; Colao A; Lombardi G; Salvatore M
J Nucl Med; 1995 Dec; 36(12):2248-51. PubMed ID: 8523115
[TBL] [Abstract][Full Text] [Related]
17. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
[TBL] [Abstract][Full Text] [Related]
19. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
Vattimo A; Bertelli P; Cintorino M; Burroni L; Volterrani D; Vella A; Lazzi S
J Nucl Med; 1998 May; 39(5):822-5. PubMed ID: 9591583
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
